Assessment of Rituximab's Immunomodulatory Synovial Effects (The ARISE Study)

Part of paid clinical trials in La Jolla, California.

Sponsor
University of California, San Diego
Study ID
NCT00147966
Phase
PHASE2
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 75 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

Using repeated arthroscopic biopsies of patients with rheumatoid arthritis, the researchers will assess changes in the immune response that occur as a result of treatment with rituximab.

Key Dates

Start date
Jun 30, 2008
Status verified
Jun 2008
Primary completion
Dec 31, 2009
Completion
Dec 31, 2009

Study Design

Enrollment
24 participants (actual)
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC

Arms

  • Experimental: ritxumab
    all patients get treatment

Primary Outcome Measure

American College of Rheumatology (ACR) 20 at Week 12 [ Time Frame: 0 and 12 weeks ]

Locations (1)

FacilityCityStateZIPSite coordinators
UCSD CITLa JollaCalifornia92093-

Find similar trials in La Jolla, CA

By condition
Rheumatoid arthritis
By specialty
RheumatologyAutoimmune diseaseMusculoskeletal disorders
By research site
UCSD CIT· La Jolla, CA

Related Studies